Detalhe da pesquisa
1.
Pharmacogenetic variants and response to neoadjuvant single-agent doxorubicin or docetaxel: a study in locally advanced breast cancer patients participating in the NCT00123929 phase 2 randomized trial.
Pharmacogenet Genomics
; 28(11): 245-250, 2018 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-30334909
2.
Regulatory CDH4 Genetic Variants Associate With Risk to Develop Capecitabine-Induced Hand-Foot Syndrome.
Clin Pharmacol Ther
; 109(2): 462-470, 2021 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-32757270
3.
Exome sequencing of three cases of familial exceptional longevity.
Aging Cell
; 13(6): 1087-90, 2014 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-25116423
4.
A polymorphism in the cytidine deaminase promoter predicts severe capecitabine-induced hand-foot syndrome.
Clin Cancer Res
; 17(7): 2006-13, 2011 Apr 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-21325291